General MedicationsORALGeneric
SONORX
SIMETHICONE-CELLULOSE
Standard Dose
7.5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SONORX is listed in Drugs@FDA under application 020773 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SIMETHICONE-CELLULOSE Form and strength SUSPENSION;ORAL - 7.5MG/ML Sponsor BRACCO Submission history Latest submission status date: 1998-10-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview SONORX is listed in Drugs@FDA under application 020773 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SIMETHICONE-CELLULOSE Form and strength SUSPENSION;ORAL - 7.5MG/ML Sponsor BRACCO Submission history Latest submission status date: 1998-10-29 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.